Key Concepts in ECP Management with the Therakos® CELLEX® Photopheresis System
Mallinckrodt Pharmaceuticals is pleased to be hosting a two-part educational program on ECP Management with Therakos® CELLEX® Photopheresis System. With each activity designed to build on the previous, a one-hour educational webinar be hosted, followed by a face-to-face workshop at the ASFA 2019 Annual Meeting on May 16.
Part 1 - Webinar Recording
Title: Key Concepts in ECP Management with the Therakos® CELLEX® Photopheresis System Date: Wednesday, April 24, 2019 Speakers: James Greco, RN
Discuss 5 phases of the ECP procedure that respond well to critical thinking and in-depth instrument knowledge:
Kit Installation and Prime Alarm Management
Troubleshooting Red Cell Pump Alarms
Troubleshooting System Pressure Alarms during Buffy Coat
Post Procedural Heparin and Fluid Balance Calculations
Apply knowledge of phases to real world clinical scenarios
View the webinar recording below.
Part 2 - Live Workshop at ASFA 2019 Annual Meeting
Title: Key Concepts in ECP Management with the Therakos® CELLEX® Photopheresis System - Part 2 Date: Thursday, May 16, 2019 Time: 7:00pm - 9:30pm PT
Participate in a 5-station rotation onsite at ASFA 2019 where the concepts discussed in the webinar will be demonstrated or discussed to maximize learning retention.
Please note that space is limited and registration will be taken on a first-come-first-served basis.
Please see Full Prescribing Information and Important Safety Information, including BOXED WARNING for UVADEX®, at www.Therakos.com. CAUTION: Read the THERAKOS® UVAR XTS® or THERAKOS® CELLEX® PHOTOPHERESIS SYSTEMS’ OPERATOR’S MANUAL prior to prescribing or dispensing this medication.
This webinar is hosted and supported by Mallinckrodt Pharmaceuticals through an unrestricted educational grant. The information included has not been reviewed or endorsed by ASFA, and cannot substitute for the advice or direction of a health care professional, and the association makes no guarantees, nor can it assume any legal liability for the accuracy, completeness, or usefulness of such information or for any damage incurred directly or indirectly from the information. Reference to any specific product does not imply its endorsement, recommendation or preference by the American Society for Apheresis.